Drug Targets for Fungal-Associated Respiratory Disorders

Proteins from the fungus Alternaria have importance in the pathogenesis of some chronic respiratory allergies and disorders.  This technology identifies fungal proteins that are critical for the onset of these diseases and are potential drug targets.
US Patent 7,662,400
US Patent 7,887,820
US Patent 7,972,611
Patent Information:
App Type Country Serial No. Patent No. File Date Issued Date Patent Status
US Utility *United States 11/580,454 7,662,400 10/13/2006 2/16/2010 Issued
US Divisional *United States 12/835,592 7,887,820 7/13/2010 2/15/2011 Abandoned
US Divisional *United States 12/973,100 7,972,611 12/20/2010 7/5/2011 Expired/Unpaid Fees
Drug Screening
For Information, Contact:
Mike Miller
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9228
Christopher Lawrence
Pharmaceuticals & Biotechnology